Obstetrics & Gynecology Doctors in Presque Isle, ME Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Louis Wesley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000

Dr. John O Langley, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 140 Academy St, Suite 4, Presque Isle, ME 04769 Phone: 207-768-5944    Fax: 207-768-3203

Dr. Rachel Mary Swartz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St Ste 4, Presque Isle, ME 04769 Phone: 207-768-5944    Fax: 207-768-3203

Dr. Joyce Marie Hebert, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Suite 4, Presque Isle, ME 04769 Phone: 207-768-5944    Fax: 207-768-3203

News Archive

Viatronix's V3D-Colon software used in another clinical study relating to colorectal cancer screening

Viatronix Incorporated announced today that its dedicated CT Colonography software—V3D-Colon was exclusively used in another important clinical study relating to colorectal cancer screening.

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.

Contact dermatitis or contact eczema?

There is allergic contact dermatitis, which is mediated through an immune mechanism, this means that the person is specifically allergic to what they have come in to contact with their skin. Their body has had to go through a process whereby they have...

Added benefit of nalmefene not proven for alcohol dependence

Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate detoxification. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in this patient group.

Read more Medical News

› Verified 3 days ago